While our study illustrates the associations between STIM1 genetic variants and clinical stage, we also found that patients with the risk alleles of rs2304891 or rs3750996 have a higher risk of late-stage breast cancer especially in ER+ or PR+ tumors. This evidence concerns the gene PGR and breast cancer.